Evidence map›Paper›PMID 29500419›Full record

ArticleScientific reports2018

Identification of genomic differences among peripheral arterial beds in atherosclerotic and healthy arteries.

Marja Steenman, Olivier Espitia, Blandine Maurel, Beatrice Guyomarch, Marie-Françoise Heymann, Marc-Antoine Pistorius, Benjamin Ory, Dominique Heymann, Rémi Houlgatte, Yann Gouëffic and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 158 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Marja Steenmanl'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.ORCID 0000-0003-4547-4448
Olivier EspitiaUMR1238 INSERM, Université de Nantes, CHU de Nantes, Nantes, France.
Blandine MaurelUMR1238 INSERM, Université de Nantes, CHU de Nantes, Nantes, France.
Beatrice Guyomarchl'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.
Marie-Françoise HeymannInstitut de Cancérologie de l'Ouest, INSERM, U1232, Université de Nantes, Nantes, France.
Marc-Antoine PistoriusDepartment of Internal Medicine, CHU de Nantes, Nantes, France.
Benjamin OryUMR1238 INSERM, Université de Nantes, CHU de Nantes, Nantes, France.
Dominique HeymannDepartment of Oncology and Metabolism, University of Sheffield, INSERM, European Associated Laboratory "Sarcoma Research Unit", Sheffield, UK.
Rémi HoulgatteINSERM U1256, NGERE, University of Nancy, Nancy, France.
Yann GouëfficUMR1238 INSERM, Université de Nantes, CHU de Nantes, Nantes, France.
Thibaut QuillardUMR1238 INSERM, Université de Nantes, CHU de Nantes, Nantes, France. thibaut.quillard@univ-nantes.fr.
Inserm · FRCentre National de la Recherche Scientifique · FRCentre Hospitalier Universitaire de Nantes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcification is independently associated with cardiovascular events and morbidity. The calcification burden in atherosclerotic lesions quantitatively and qualitatively differs between arterial beds. Cardiovascular risk factors (CVRF) differentially affect plaque development between arterial beds. The aim of this study was to evaluate the impact of CVRF on atherosclerotic plaque calcification and to further study the molecular arterial heterogeneity that could account for these differences. Histological analysis was performed on atherosclerotic plaques from 153 carotid, 97 femoral and 28 infrapopliteal arteries. CVRF showed minor associations with plaque calcification: age and hypertension affected only the overall presence of calcification but not the type of the calcification, which significantly differed between arterial beds. Transcriptome analysis revealed distinct gene expression profiles associated with each territory in atherosclerotic and healthy arteries. Canonical pathway analysis showed the preferential involvement of immune system-related processes in both atherosclerotic and healthy carotid arteries. Bone development-related genes were among those mostly enriched in atherosclerotic and healthy femoral arteries, which are more prone to developing endochondral calcification. This study highlights the heterogeneous nature of arteries from different peripheral vascular beds and contributes to a better understanding of atherosclerosis formation and evolution.

Indexed as

Genome, HumanAgedArteriesAtherosclerosisCalcinosisCase-Control StudiesFemaleGene Expression ProfilingHumansMaleMiddle AgedPlaque, AtheroscleroticRisk Factors

Identifiers

PMID29500419
PMCPMC5834518
OpenAlexW2805484788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.